In an elegant experiment by researchers at MD Anderson Cancer Center, the effects of adenoviral-mediated p53 transgene expression on the radiation response of two human prostate cancer cell lines, LNCaP and PC3 lines, was examined. Here, TP53 is linked to prostate carcinoma.